Early Results of a Phase II Study of Ofatumumab As Front-Line Treatment in Elderly, Unfit Patients with Chronic Lymphocytic Leukemia (CLL)

被引：1

作者：

Ciccone, Maria ^{[1
]}

Vitale, Candida ^{[1
]}

Hinojosa, Christina ^{[1
]}

Keating, Michael J. ^{[1
]}

Pemmaraju, Naveen ^{[1
]}

O'Brien, Susan ^{[1
]}

Burger, Jan A. ^{[1
]}

Thomas, Deborah A. ^{[1
]}

Kantarjian, Hagop M. ^{[1
]}

Strati, Paolo ^{[1
]}

Wierda, William G. ^{[1
]}

Ferrajoli, Alessandra ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

10.1182/blood.V124.21.5656.5656

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] Management of elderly and unfit patients with chronic lymphocytic leukemia
Mauro, Francesca R.
Salaroli, Adriano
Caputo, Maria D.
Colafigli, Gioia
Petrucci, Luigi
Campanelli, Melissa
Ferretti, Antonietta
Guarini, Anna R.
Foa, Robin
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (12) : 1165 - 1175
[32] A phase II study of lenalidomide as initial treatment of elderly patients with chronic lymphocytic leukemia
Badoux, X.
Wierda, W. G.
O'Brien, S. M.
Faderl, S.
Estrov, Z.
Yerrow, K. A.
Keating, M. J.
Ferrajoli, A.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[33] FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia
Kutsch, Nadine
Busch, Raymonde
Bahlo, Jasmin
Mayer, Jiri
Hensel, Manfred
Hopfinger, Georg
Hess, Georg
von Gruenhagen, Ulrich
Wendtner, Clemens-Martin
Fink, Anna Maria
Fischer, Kirsten
Hallek, Michael
Eichhorst, Barbara
LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 399 - 407
[34] AN ASSESSMENT OF THE NUMBER OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS ELIGIBLE FOR FRONT-LINE TREATMENT BUT UNSUITABLE FOR FULL DOSE FLUDARABINE ACROSS THE EUROPEAN UNION
Jeyakumaran, D.
Kempel, A.
Cote, S.
VALUE IN HEALTH, 2016, 19 (07) : A574 - A575
[35] Combination of Ofatumumab and Lenalidomide In Patients with Relapsed Chronic Lymphocytic Leukemia: Initial Results of a Phase II Trial
Badoux, Xavier
O'Brien, Susan
Wierda, William G.
Faderl, Stefan
Estrov, Zeev
Yerrow, Kimberly
Kantarjian, Hagop M.
Keating, Michael J.
Ferrajoli, Alessandra
BLOOD, 2010, 116 (21) : 1023 - 1024
[36] Front-Line Treatment Options for Chronic-Phase Chronic Myeloid Leukemia
Shah, Neil P.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (03) : 220 - +
[37] Lenalidomide as Initial Treatment of Elderly Patients with Chronic Lymphocytic Leukemia (CLL)
Ferrajoli, Alessandra
O'Brien, Susan
Wierda, William
Faderl, Stefan
Kornblau, Steven
Yerrow, Kimberly
Estrov, Zeev
Kantarjian, Hagop
Keating, Michael
BLOOD, 2008, 112 (11) : 23 - 23
[38] Historical Trends in the Front-Line Treatment in Patients With Chronic Lymphocytic Leukemia: Experience from a European Center
Arguello-Tomas, Miguel
Albiol, Nil
Jara, Paola
Sierra, Jordi
Mora, Alba
Moreno, Carol
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S280 - S280
[39] Front-line treatment of patients with chronic lymphocytic leukemia: a systematic review and network meta-analysis
Xu, Yingxin
Fahrbach, Kyle
Dorman, Emily
Baculea, Simona
Cote, Sarah
van Sanden, Suzy
Diels, Joris
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (05) : 421 - 441
[40] FRONT-LINE FLUDARABINE, CYCLOPHOSPHAMIDE, OFATUMUMAB CHEMOIMMUNOTHERAPY IN YOUNG (≤65 YRS) AND FIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. PRELIMINARY RESULTS OF THE PHASE 2, MULTICENTER GIMEMA STUDY LLC0911
Mauro, F. R.
Zaja, F.
Molica, S.
Coscia, M.
Liberati, A. M.
Piciocchi, A.
Ilariucci, I.
Russo, F.
Tedeschi, A.
Baraldi, A.
Carella, A. M.
Del Poeta, G.
Cortelezzi, A.
Gozzetti, A.
Ferretti, A.
Iannella, E.
Del Giudice, I.
Della Starza, I.
De Propris, M. S.
Marinelli, M.
Nanni, M.
Fazi, P.
Vignetti, M.
Neri, A.
Specchia, G.
Cuneo, A.
Guarini, A.
Foa, R.
HAEMATOLOGICA, 2015, 100 : 28 - 28

← 1 2 3 4 5 →